Absci Corporation (ABSI)
NMS – Real vaqt narxi. Valyuta: USD
5.36
-0.42 (-7.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
5.36
-0.42 (-7.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Absci Corporation, klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda turli xil antiteloterapiya vositalarini ishlab chiqadi. Uning preklinik rivojlanish dasturlari orasida yallig'lanishli ichak kasalliklarini davolash uchun 1-faza klinik sinovlarida bo'lgan ABS-101; androgenetik alopetsiyani davolash uchun 1/2a faza klinik sinovlarida bo'lgan prolaktin retseptoriga (PRLR) qarshi antitelosi bo'lgan ABS-201; immüno-onkologiyani davolash uchun ABS-301; va onkologiyani davolash uchun ABS-501 mavjud. Absci Corporation qo'shma ilmiy-tadqiqot va ishlanmalar bo'yicha PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation va Advanced Micro Devices, Inc. bilan hamkorlik shartnomalariga ega. Kompaniya 2011-yilda tashkil etilgan va shtab-kvartirasi Vankuver, Vashingtonda joylashgan.
| Ism | Lavozim |
|---|---|
| Amir Shanehsazzadeh | Chief AI Officer |
| Dr. Christine Lemke D.V.M., M.B.A., Ph.D. | Senior Vice President of Portfolio & Growth Strategy |
| Dr. Ransi Somaratne FACC, M.B.A., M.D. | Chief Medical Officer |
| Dr. Zachariah Jonasson Ph.D. | Chief Business Officer & CFO |
| Mr. Alexander Khan CPA | CVP of Finance & Head of Investor Relations |
| Mr. Sean McClain | Founder, CEO, President & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | absc-20260507.htm |
| 2026-05-07 | 10-Q | absi-20260331.htm |
| 2026-04-22 | DEFA14A | proxyadditionalmaterials20.htm |
| 2026-03-24 | S-8 | s-8x2026x03x2026evergreeni.htm |
| 2026-03-06 | 8-K | absc-20260303.htm |
| 2026-01-14 | 8-K | absc-20260114.htm |
| 2025-11-12 | 8-K | absc-20251112.htm |
| 2025-11-12 | 10-Q | absi-20250930.htm |
| 2025-11-04 | 8-K | absc-20251031.htm |
| 2025-08-20 | CORRESP | filename1.htm |
| Mr. Todd Bedrick CPA | Senior VP & Chief Accounting Officer |
| Mr. Wen Sha | Chief of Staff |
| Ms. Jeanne Schreuder M.B.A., SPHR | Senior Vice President of People & Experience |
| Ms. Shelby Walker J.D. | Chief Legal Officer |